✦ LIBER ✦

Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

✍ Scribed by Charles Kunos, Tomas Radivoyevitch, Fadi W Abdul-Karim, James Fanning, Ovadia Abulafia, Albert J Bonebrake, Lydia Usha

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altretamine (Hexamethylmelamine) in Plat

✍ Maurie Markman; John A. Blessing; David Moore; Harrison Ball; Samuel S. Lentz 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase II Trial of Pyrazoloacridine in Re

✍ Steven C. Plaxe; John A. Blessing; Michael A. Bookman; William T. Creasman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Tamoxifen in Platinum-Refractory Ovarian

✍ Maurie Markman; Karen A. Iseminger; Kenneth D. Hatch; William T. Creasman; Willa 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Evaluation of Cisplatin and Cyclosporin

✍ Alberto Manetta; John A. Blessing; Jean A. Hurteau 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 29 KB

A Phase II Trial of CI-958 in Recurrent

✍ Mark A. Hoffman; John A. Blessing; Evelyn R. Nuñez 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 34 KB

A phase II trial of dolastatin-10 in rec

✍ Mark A Hoffman; John A Blessing; Samuel S Lentz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 56 KB